Canasmart Tablet (Canagliflozin)

Precautions & Warnings Of Canasmart Tablet (Canagliflozin) 

• Elderly patients: elevated risk of dehydration, hypotension, dizziness, syncope 
• Volume depletion: especially with concurrent diuretics or RAS-inhibiting drugs—monitor blood pressure and renal function 
• Bone health: increased fracture risk, particularly in older adults 
• Lower limb risk: potential amputations—patients with peripheral arterial disease, neuropathy, foot ulcers should have routine preventive foot
• Prevent and promptly treat genital and urinary infections
• Teach patients signs of DKA—even with normal glucose—and to seek immediate care if symptoms develop 
• Allergy warnings—discontinue use if hypersensitivity occurs 
• Avoid during pregnancy and breastfeeding unless benefits outweigh 
• Urine glucose tests will be positive—monitor glycemic control with blood, not urine 
• Patients should remain hydrated, especially during illness, surgery, or stress, and not discontinue without medical advice

Uses Of Canasmart Tablet (Canagliflozin) 

Canasmart (Canagliflozin) is indicated to:

• Lower blood glucose levels in adults with type 2 diabetes, when used in conjunction with diet and exercise. 
• Reduce the risk of major cardiovascular events—such as heart attack, stroke, or cardiovascular death—in patients with type 2 diabetes and established cardiovascular disease. 
• Decrease the risk of progression to end-stage kidney disease, worsening renal function, and hospitalization from heart failure in patients with diabetic kidney disease featuring albuminuria.

Side Effects Of Canasmart Tablet (Canagliflozin) 

Common Side Effects (≥5% of patients):

• Genital mycotic (yeast) infections (vaginal or penile)
• Urinary tract infections (UTIs)
• Increased urination (polyuria) 

Serious Side Effects—Seek medical attention immediately if experienced:

• Light-headedness or fainting, possibly due to dehydration or low blood pressure
• Pain or burning during urination, or markedly reduced urine output
• New sores, infections, or pain in legs or feet (including ulcers or infections of the foot)
• Hyperkalemia (high potassium): nausea, irregular heartbeat, weakness, muscle control issues
• Diabetic ketoacidosis (DKA): nausea, vomiting, abdominal pain, confusion, excessive drowsiness, or trouble breathing—even if blood sugar is not elevated
• Increased fracture risk
• Necrotizing fasciitis of the perineum (Fournier’s gangrene): genital or perineal pain, swelling, redness, fever
• Hypersensitivity reactions: hives, swelling, difficulty breathing, 

Frequently Asked Questions Of Canasmart Tablet (Canagliflozin) 

What time of day should I take Canasmart?
Take once daily, before your first meal of the day, ideally in the morning consistently. 

Can I stop taking it if I feel good?
No—this medication controls, not cures, type 2 diabetes. Continue as prescribed; do not stop without consulting your doctor. 

Will it affect routine urine glucose tests?
Yes. Canagliflozin increases urinary glucose excretion—urine tests will be unreliable. Use blood glucose or A1C monitoring. 

Is there a risk of low blood sugar?
Not usually on its own. However, when combined with insulin or insulin-secretagogues, hypoglycemia may occur—monitor glucose carefully. 

What should I do if I miss a dose?
Take it as soon as you remember—unless close to the next dose. Do not double dose. 

Does Canasmart benefit kidney health?
Yes—in patients with type 2 diabetes and kidney disease, it reduces risk of progression to end-stage renal disease, worsening function, and hospitalizations for heart failure. 

What signs indicate a serious side effect?
Seeks medical attention for signs of DKA (e.g., nausea, abdominal pain, confusion), severe infection, limb pain/sores, or fainting.

Interactions Of Canasmart Tablet (Canagliflozin) 

• UGT Enzyme Inducers (e.g., rifampin, phenobarbital, phenytoin, ritonavir): reduce Canagliflozin exposure—may require dose increase (up to 300 mg, depending on renal function) 
• Digoxin: Canagliflozin increases digoxin exposure by ~20–36%; monitor levels and adjust dose if needed 
• Loop Diuretics: combined use may amplify hypotension risk—correct volume status and monitor closely 
• Cyclosporine: small increases; typically no adjustment needed 
• Acetaminophen: no clinically significant interaction